Company intelligence / Profile preview

Synerlab

Ownership: Private
Employees: ~800
Development stage: Commercial

Overview

Synerlab provides end-to-end pharmaceutical development and manufacturing services across Europe. They specialize in small and medium batch production for oral solids, sterile/nonsterile liquids, semi-solids, lyophilized products, and clinical trial materials. Their expertise includes regulatory affairs support and technology transfer. They serve both large pharma companies and small biotech startups with flexible project management focused on quality and efficiency.

Modalities: Small molecule (oral solid dose, tablets, capsules)Biologic (sterile multidose liquids, lyophilized products)Semi-solid (creams, gels)Medical device (limited; some sites mention medical devices as part of their offering)Freeze-dried product therapyLiquid formulation
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Synerlab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synerlab.

Explore the full profile